Cardiac Glycosides: From Natural Defense Molecules to Emerging Therapeutic Agents
Open Access
- 17 June 2025
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 15 (6) , 885
Abstract
Cardiac glycosides (CGs), a class of plant- and animal-derived compounds historically used to treat heart failure, have garnered renewed interest for their diverse pharmacological properties beyond Na+/K+-ATPase (NKA) inhibition. Recent studies reveal that CGs modulate key signaling pathways—such as NF-κB, PI3K/Akt, JAK/STAT, and MAPK—affecting processes central to cancer, viral infections, immune regulation, and neurodegeneration. In cancer, CGs induce multiple forms of regulated cell death, including apoptosis, ferroptosis, pyroptosis, and immunogenic cell death, while also inhibiting angiogenesis, epithelial–mesenchymal transition, and cell cycle progression. They demonstrate broad-spectrum antiviral activity by disrupting viral entry, replication, and mRNA processing in viruses such as HSV, HIV, influenza, and SARS-CoV-2. Immunologically, CGs regulate Th17 differentiation via RORγ signaling, although both inhibitory and agonistic effects have been reported. In the nervous system, CGs modulate neuroinflammation, support synaptic plasticity, and improve cognitive function in models of Alzheimer’s disease, epilepsy, and multiple sclerosis. Despite their therapeutic potential, clinical translation is hindered by narrow therapeutic indices and systemic toxicity. Advances in drug design and nanocarrier-based delivery are critical to unlocking CGs’ full potential as multi-target agents for complex diseases. This review synthesizes the current knowledge on the emerging roles of CGs and highlights strategies for their safe and effective repurposing.Keywords
Funding Information
- National Research Council of Mexico (CONAHCYT) (CF-2019-7357)
This publication has 315 references indexed in Scilit:
- Telocinobufagin suppresses malignant metastasis of undifferentiated thyroid carcinoma via modulation of the LARP1‐mTOR pathwayThe Kaohsiung Journal of Medical Sciences, 2025
- Arenobufagin Induces Ferroptosis in Glioblastoma Cells via Modulating the MiR‐149‐5p/AEBP1 AxisJournal of Applied Toxicology, 2024
- Research Progress on Plant‐Derived Cardenolides (2010–2023)Chemistry & Biodiversity, 2024
- Separation of bufadienolides from Helleborus thibetanus Franch. by a combination approach involving macroporous resin column chromatography and gradient countercurrent chromatographyJournal of Separation Science, 2024
- Toad venom bufadienolides and bufotoxins: An updated reviewDrug Development Research, 2023
- Bufalin induces apoptosis and autophagy via the Ca2+/CaMKKβ/AMPK/Beclin1 signaling pathway in osteosarcoma cellsCell Biology International, 2023
- Discovery of Novel 3,11‐Bispeptide Ester Arenobufagin Derivatives with Potential in Vivo Antitumor Activity and Reduced CardiotoxicityChemistry & Biodiversity, 2023
- Repurposing the cardiac glycoside digoxin to stimulate myelin regeneration in chemically‐induced and immune‐mediated mouse models of multiple sclerosisGlia, 2022
- Targeting immunogenic cell death in cancerMolecular Oncology, 2020
- Die herzaktiven Substanzen der Meerzwiebel. Scillaren AHelvetica Chimica Acta, 1933